ARTICLE | Clinical News
Diazepam nasal spray regulatory update
December 16, 2013 8:00 AM UTC
Acorda said it submitted an NDA to FDA for its diazepam nasal spray to treat acute repetitive seizures in epileptics. The company submitted the product under section 505(b)(2) of the Food, Drug and Co...